HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Michael Lewiecki Selected Research

Eczema

10/2014Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis.
12/2010Clinical use of denosumab for the treatment for postmenopausal osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Michael Lewiecki Research Topics

Disease

107Osteoporosis
03/2024 - 11/2002
36Postmenopausal Osteoporosis
02/2024 - 06/2005
29Bone Resorption
02/2024 - 06/2005
16Metabolic Bone Diseases (Osteopenia)
10/2023 - 12/2005
9Osteonecrosis (Kienbock's Disease)
05/2020 - 09/2008
7Neoplasms (Cancer)
10/2023 - 10/2006
6Hypophosphatasia
11/2023 - 10/2017
5Osteoporotic Fractures
01/2023 - 07/2012
5Hip Fractures (Intertrochanteric Fractures)
01/2023 - 06/2010
5Bone Diseases (Bone Disease)
10/2022 - 01/2016
4Breast Neoplasms (Breast Cancer)
10/2023 - 07/2006
3Prostatic Neoplasms (Prostate Cancer)
10/2023 - 04/2015
3Femoral Fractures (Femoral Fracture)
05/2020 - 10/2016
3Hyperparathyroidism
08/2015 - 02/2009
3Cellulitis
10/2014 - 12/2010
3Rheumatoid Arthritis
07/2009 - 10/2006
2Oncogenic osteomalacia
10/2022 - 03/2008
2Hypophosphatemia
01/2022 - 03/2008
2Necrosis
10/2020 - 10/2006
2Hypercalcemia (Milk Alkali Syndrome)
01/2017 - 10/2010
2Vitamin D Deficiency
08/2015 - 01/2003
2Eczema
10/2014 - 12/2010
2Atrial Fibrillation
01/2013 - 07/2012
2Esophageal Neoplasms (Esophageal Cancer)
01/2013 - 07/2012
2Neoplasm Metastasis (Metastasis)
12/2009 - 07/2006
2Infections
07/2009 - 07/2009
2Multiple Myeloma
10/2006 - 07/2006
1Chronic Disease (Chronic Diseases)
03/2024
1Osteogenesis Imperfecta (Lobstein Disease)
10/2022
1Primary Hyperparathyroidism
10/2022
1Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
10/2022
1Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
10/2022
1Osteopetrosis
10/2022
1Periprosthetic Fractures
01/2022
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2020
1COVID-19
09/2020
1Bone Fractures (Bone Fracture)
01/2019
1Second Primary Neoplasms (Neoplasms, Second)
01/2016
1Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
07/2015

Drug/Important Bio-Agent (IBA)

33DenosumabFDA Link
01/2023 - 02/2006
25Diphosphonates (Bisphosphonates)IBA
01/2023 - 11/2002
17Monoclonal AntibodiesIBA
11/2022 - 07/2006
12romosozumabIBA
02/2024 - 01/2011
10Vitamin DFDA LinkGeneric
10/2023 - 07/2006
10Teriparatide (Parathar)FDA Link
01/2023 - 06/2005
10RANK LigandIBA
11/2018 - 07/2006
9CalciumIBA
10/2020 - 01/2003
9Parathyroid Hormone (Parathormone)IBA
05/2020 - 01/2012
8Zoledronic Acid (Zometa)FDA Link
05/2020 - 01/2008
8CytokinesIBA
11/2018 - 07/2006
7Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2020 - 11/2002
6MineralsIBA
05/2020 - 01/2006
5Bone Density Conservation AgentsIBA
03/2024 - 04/2009
5abaloparatideIBA
10/2023 - 01/2017
5Raloxifene Hydrochloride (Evista)FDA Link
01/2023 - 04/2007
5Anabolic AgentsIBA
11/2022 - 01/2013
5Collagen Type I (Type I Collagen)IBA
01/2021 - 04/2010
5LigandsIBA
07/2017 - 02/2009
5Biomarkers (Surrogate Marker)IBA
01/2016 - 06/2005
4N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
11/2023 - 10/2017
4Estrogens (Estrogen)FDA Link
01/2020 - 10/2007
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 07/2006
4Ibandronic Acid (Boniva)FDA Link
04/2010 - 08/2005
3Alkaline PhosphataseIBA
11/2023 - 06/2005
3hydroxide ionIBA
05/2020 - 09/2016
3AndrogensIBA
11/2018 - 10/2006
3Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
09/2016 - 03/2010
3bazedoxifeneIBA
10/2009 - 10/2007
3Selective Estrogen Receptor Modulators (SERM)IBA
10/2009 - 10/2007
2N-succinimidyl 8-((4'-fluorobenzyl)amino)suberateIBA
10/2023 - 10/2022
2strontium ranelate (protelos)IBA
01/2023 - 04/2007
2ProcollagenIBA
01/2021 - 06/2005
225-hydroxyvitamin DIBA
05/2020 - 03/2008
2GlucocorticoidsIBA
11/2018 - 07/2004
2Aromatase InhibitorsIBA
11/2018 - 10/2006
2Phosphates (Orthophosphate)IBA
04/2017 - 03/2008
24-nitrobenzyloxyamineIBA
09/2016 - 09/2016
2odanacatibIBA
09/2011 - 12/2009
2Cathepsin KIBA
09/2011 - 12/2009
2LasofoxifeneIBA
10/2009 - 01/2009
2Methotrexate (Mexate)FDA LinkGeneric
07/2009 - 07/2009
1EnzymesIBA
11/2023
1Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA
11/2022
1Gonadal HormonesIBA
10/2020
1procollagen Type I N-terminal peptideIBA
05/2020
1eculizumabFDA Link
07/2017
1Parathyroid Hormone-Related ProteinIBA
01/2017
1salmon calcitonin (Calcimar)FDA LinkGeneric
06/2016
1SteroidsIBA
08/2015

Therapy/Procedure

64Therapeutics
03/2024 - 01/2003
5Subcutaneous Injections
12/2022 - 06/2005
4Fracture Fixation
04/2020 - 02/2013
3Injections
07/2017 - 11/2007
3Intravenous Infusions
06/2010 - 01/2008
2Drug Therapy (Chemotherapy)
10/2020 - 10/2006
2Duration of Therapy
01/2017 - 01/2016
2Contraindications
10/2014 - 11/2007
1Cell Transplantation
10/2020
1Bariatric Surgery
01/2020
1Orthopedic Procedures
01/2019